Skip to content

The effect of oxytocin and vasopressin in reducing laparoscopic myomectomy bleeding in women

Comparison of intra-myomic injection of oxytocin and intramural vasopressin in reducing laparoscopic myomectomy bleeding in women with myoma

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150817023666N15
Enrollment
60
Registered
2022-07-03
Start date
2022-07-21
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding during surgery.

Interventions

Intervention 1: Control group: Prophylaxis oxytocin is diluted and injected intramyometrialy (between the myoma and the uterus) and subcapsulary. For this purpose, a 10 mg ampoule is diluted with 300

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age of 20 to 45 years Symptomatic uterine fibroids candidate for laparoscopic surgery No response to drug treatment

Exclusion criteria

Exclusion criteria: Underlying diseases related to blood factors Pregnancy Women who are candidates for hysterectomy People for whom anesthesia is harmful A history of an adverse reaction or allergy to vasopressin, and an active cardiovascular or pulmonary disease that indicates a problem with vasopressin use. Long QT interval Leiomyoma located in the area of the uterus that connects to the arteries or ligaments of the uterus or cervix and is difficult to remove without hysterectomy.

Design outcomes

Primary

MeasureTime frame
Bleeding during surgery. Timepoint: The volume of suctioned blood is measured during the operation, after surgery and 12 hours after the operation. Method of measurement: Measurement of blood hemoglobin.

Secondary

MeasureTime frame
Duration of surgery. Timepoint: Before and after surgery and 12 hours after surgery. Method of measurement: Patient's file (document).;Duration of hospitalization. Timepoint: Before and after surgery and 12 hours after surgery. Method of measurement: Patient's file (document).;Postoperative side effects such as allergies. Timepoint: Before and after surgery and 12 hours after surgery. Method of measurement: Patient's file (document).;Cardiovascular disorders. Timepoint: Before and after surgery and 12 hours after surgery. Method of measurement: Patient's file (document).;Pulmonary edema. Timepoint: Before and after surgery and 12 hours after surgery. Method of measurement: Patient's file (document).;Fever. Timepoint: Before and after surgery and 12 hours after surgery. Method of measurement: Patient's file (document).;Infection. Timepoint: Before and after surgery and 12 hours after surgery. Method of measurement: Patient's file (document).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Mehdizadeh Kashi

Iran University of Medical Sciences

mehdizadeh.a@iums.ac.ir+98 21 6435 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026